Total no. of patients | 41 |
---|---|
Age, years | |
Mean ± SD | 72,5 ± 7,5 |
Range | 56–87 |
Sex, no. (%) | |
Male | 37 (90) |
Female | 4 (10) |
KPS, no. (%) | |
70 | 9 (22) |
80 | 17 (41) |
90 | 15 (37) |
100 | 0 |
T-Stage, no. (%) | |
T1 | 2 (5) |
T2 | 9 (22) |
T3 | 13 (32) |
T4 | 17 (41) |
N-Stagea, no. (%) | |
N0 | 2 (5) |
N1 | 5 (12) |
N2 | 31 (76) |
N3 | 3 (7) |
UICC stage, no. (%) | |
IIB | 3 (7) |
IIIA | 17 (42) |
IIIB | 21 (51) |
FEV1, % predicted | |
Mean ± SD | 63 ± 15 |